CRVS

NASDAQStock

Corvus Pharmaceuticals, Inc.

$16.18-0.72 (-4.26%)

52-Week Range

$2.82
$25.52

Key Stats

Market Cap

1.4B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Volume

916.8K

Avg Volume

1.1M

Performance

1M

-18.90%

3M

+90.82%

6M

+172.28%

YTD

+118.72%

1Y

+255.78%

3Y

+2247.16%

5Y

+388.11%

Price Chart

ETF Exposure

CRVS is held by 47 ETFs

ETFFund NameWeight
BBCVirtus Biotech Clinical Trials ETF1.49%
CANCTema Oncology ETF1.05%
IDNAiShares Genomics Immunology and Healthcare ETF1.00%
SBIOALPS Medical Breakthroughs ETF0.80%
SURISimplify Propel Opportunities ETF0.44%
XBIState Street SPDR S&P Biotech ETF0.35%
IWCiShares Micro-Cap ETF0.20%
FSMLFranklin Small Cap Enhanced ETF0.10%
IBBQInvesco Nasdaq Biotechnology ETF0.09%
IBBiShares Biotechnology ETF0.09%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.09%
VFMOVanguard U.S. Momentum Factor ETF0.08%
VTWGVanguard Russell 2000 Growth ETF0.07%
LABUDirexion Daily S&P Biotech Bull 3X ETF0.07%
BIBProShares - Ultra Nasdaq Biotechnology0.07%
TNXTT. Rowe Price Innovation Leaders ETF0.05%
VTWOVanguard Russell 2000 ETF0.04%
PWSPacer WealthShield ETF0.03%
IWMiShares Russell 2000 ETF0.03%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.03%
RSSLGlobal X - Russell 2000 ETF0.03%
RESMColumbia Research Enhanced Small Cap ETF0.03%
TECBiShares U.S. Tech Breakthrough Multisector ETF0.02%
UWMProShares - Ultra Russell20000.02%
URTYProShares - UltraPro Russell20000.02%
VXFVanguard Extended Market ETF0.02%
VHTVanguard Health Care ETF0.02%
SMMDiShares Russell 2500 ETF0.01%
HDGProShares - Hedge Replication ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%

About CRVS ETF Exposure

Corvus Pharmaceuticals, Inc. (CRVS) is held by 47 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.4B, CRVS is a widely held institutional stock. The stock currently trades at $16.18. Investors can gain exposure to CRVS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CRVS, sorted by portfolio weight.